BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22432085)

  • 1. Cancer-testis antigens: the current status on antigen regulation and potential clinical use.
    Lim SH; Zhang Y; Zhang J
    Am J Blood Res; 2012; 2(1):29-35. PubMed ID: 22432085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
    Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
    Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation Profile of Cancer Testis Antigens in Colorectal Cancer.
    Abu N; Rus Bakarurraini NAA; Nasir SN; Ishak M; Baharuddin R; Jamal R; Ab Mutalib NS
    Iran J Immunol; 2023 Mar; 20(1):83-91. PubMed ID: 36932973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
    Yang P; Meng M; Zhou Q
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-testis antigens in haematological malignancies.
    Meklat F; Li Z; Wang Z; Zhang Y; Zhang J; Jewell A; Lim SH
    Br J Haematol; 2007 Mar; 136(6):769-76. PubMed ID: 17223912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential immune-eliciting cancer testis antigens in colorectal cancer.
    Chi Soh JE; Abu N; Jamal R
    Immunotherapy; 2018 Sep; 10(12):1093-1104. PubMed ID: 30185136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.
    Nin DS; Deng LW
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-testis antigens in canine histiocytic sarcoma and other malignancies.
    Nemec PS; Kapatos A; Holmes JC; Stowe DM; Hess PR
    Vet Comp Oncol; 2019 Sep; 17(3):317-328. PubMed ID: 30854786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer/testis antigens: from serology to mRNA cancer vaccine.
    Fan C; Qu H; Wang X; Sobhani N; Wang L; Liu S; Xiong W; Zeng Z; Li Y
    Semin Cancer Biol; 2021 Nov; 76():218-231. PubMed ID: 33910064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma: a prototype of cancer-testis antigen-expressing malignancies.
    Faramarzi S; Ghafouri-Fard S
    Immunotherapy; 2017 Oct; 9(13):1103-1113. PubMed ID: 29032737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer testis antigens as immunogenic and oncogenic targets in breast cancer.
    Mahmoud AM
    Immunotherapy; 2018 Jul; 10(9):769-778. PubMed ID: 29926750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
    Gordeeva O
    Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens.
    Ghafouri-Fard S; Seifi-Alan M; Shamsi R; Esfandiary A
    Iran J Cancer Prev; 2015 Oct; 8(5):e3755. PubMed ID: 26634107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression, modulation and use of cancer-testis antigens as potential biomarkers for cancer immunotherapy.
    Li XF; Ren P; Shen WZ; Jin X; Zhang J
    Am J Transl Res; 2020; 12(11):7002-7019. PubMed ID: 33312347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-testis antigens: An update on their roles in cancer immunotherapy.
    Taherian-Esfahani Z; Dashti S
    Hum Antibodies; 2019; 27(3):171-183. PubMed ID: 30909205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer.
    Yang P; Qiao Y; Meng M; Zhou Q
    Front Oncol; 2022; 12():864159. PubMed ID: 35574342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets.
    Xie K; Fu C; Wang S; Xu H; Liu S; Shao Y; Gong Z; Wu X; Xu B; Han J; Xu J; Xu P; Jia X; Wu J
    J Ovarian Res; 2019 Jan; 12(1):1. PubMed ID: 30609934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application.
    Wei R; Dean DC; Thanindratarn P; Hornicek FJ; Guo W; Duan Z
    Cancer Lett; 2020 Jun; 479():54-60. PubMed ID: 31634526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of cancer/testis antigens (CTAs) in breast cancer.
    Li Y; Li J; Wang Y; Zhang Y; Chu J; Sun C; Fu Z; Huang Y; Zhang H; Yuan H; Yin Y
    Cancer Lett; 2017 Jul; 399():64-73. PubMed ID: 28274891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.